The quarter fell well short of the published revenue bar. Revenue was $7.9M versus a published consensus of roughly $22.1M, while reported EPS was approximately nil; the shortfall was driven by antimony revenue of $5.9M, down from $9.6M despite 26% higher pounds sold, as realized pricing fell 52% to $13.70 per pound (Financial Highlights; Antimony segment results).
The more important surprise was the full-year reset. Management cut 2026 gross revenue guidance to $60–75M from $125M, implying a roughly 40%–52% reduction in the prior target. The stated reasons—lower antimony prices, delayed DLA delivery timing, and a slower production ramp—directly weaken the near-term revenue case rather than merely changing accounting timing (2026 revenue guidance).
Reported profitability was weaker than the headline net income suggests. Gross profit fell to $0.6M from $2.8M, gross margin compressed to about 7% from 27%, and operating loss reached $7.0M versus break-even a year earlier. Net income of $0.1M was largely rescued by a $6.8M unrealized gain on the Larvotto investment, not by the operating business (Income Statement).
The operating buildout is progressing, but it is consuming cash before producing comparable sales. Six-month operating cash use was $20.7M, inventory rose to $21.6M from $12.5M at year-end, and capital expenditures reached $22.8M. Liquidity was supported mainly by $49.1M of net equity issuance and a $12.8M government grant, making the expansion financially funded but also more dilutive and dependent on execution (Balance Sheet; Cash Flow statement).
The offset is a credible near-term shipment pipeline, not a recovery in current results. Two DLA shipments totaling about 82,000 pounds were delivered but recognized in July, with approximately $2.6M expected in the third quarter; management also cites $57.3M of DLA orders and expects at least $9–10M of third-quarter government sales. That supports a better second half if Thompson Falls ramps on schedule, but the filing's net message is that the market's prior growth and pricing assumptions were materially too high (Shipment schedule; Management outlook).
Read the original 8-K on SEC EDGAR ↗